| __timestamp | Takeda Pharmaceutical Company Limited | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 520990000000 | 179279000 |
| Thursday, January 1, 2015 | 535405000000 | 186359000 |
| Friday, January 1, 2016 | 558755000000 | 171785000 |
| Sunday, January 1, 2017 | 495921000000 | 208136000 |
| Monday, January 1, 2018 | 659690000000 | 198405000 |
| Tuesday, January 1, 2019 | 1089764000000 | 224169000 |
| Wednesday, January 1, 2020 | 994308000000 | 245044000 |
| Friday, January 1, 2021 | 1106846000000 | 252314000 |
| Saturday, January 1, 2022 | 1244072000000 | 268225000 |
| Sunday, January 1, 2023 | 1431505000000 | 304629000 |
| Monday, January 1, 2024 | 1431505000000 | 324203000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Takeda Pharmaceutical Company Limited and Taro Pharmaceutical Industries Ltd. offer a fascinating study in contrasts. Over the past decade, Takeda's cost of revenue has surged by approximately 175%, peaking in 2023 at 1.43 trillion yen. This reflects its aggressive expansion and acquisition strategy, notably the Shire acquisition in 2019. Meanwhile, Taro's cost of revenue has grown by about 70%, reaching 324 million yen in 2024. This steady increase underscores Taro's focus on niche markets and generic drugs.
The data reveals Takeda's significant scale, with costs nearly 4,400 times higher than Taro's in 2023. This disparity highlights the diverse strategies within the pharmaceutical sector, where size and specialization both play pivotal roles. As the industry faces new challenges, these insights provide a window into the strategic decisions shaping its future.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Takeda Pharmaceutical Company Limited
Cost of Revenue Comparison: AstraZeneca PLC vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Pfizer Inc. and Taro Pharmaceutical Industries Ltd.'s Expenses
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and HUTCHMED (China) Limited's Expenses
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Mesoblast Limited
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Xencor, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Xenon Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Dyne Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Celldex Therapeutics, Inc.